Castle Biosciences (CSTL) provided an update on its test currently in development for use in patients diagnosed with moderate-to-severe atopic dermatitis, or AD, who are seeking systemic treatment ...
Environmental factors can influence gene expression, impacting brain development and health outcomes, emphasizing early intervention and public health policy for child development.
These forward-looking statements include, but are not limited to, statements concerning: the ability of Castle’s pipeline AD gene expression profile test to (i) identify a subset of patients ...